aTyr Pharma | LIFE - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Ardelyx USD 109.57M 20.96M 2026-03
aTyr Pharma USD 11.7M 101.49M 2026-03
Biogen USD 3B 350.5M 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Cipla INR 70.14B 7.16B 2026-03
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.57M 2.29M 2025-12
CSL USD 4.61B 207M 2025-12
Curis USD 14.08M 5.3M 2025-12
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Grifols EUR 2.37B 156.97M 2025-12
Lakefront Biotherapeutics EUR 100.42M 52.44M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Roche Holding CHF 28B 421M 2025-12
United Therapeutics USD 599.1M 38.5M 2026-03
Xoma USD 28.3M 6.81M 2025-09